[go: up one dir, main page]

ES2115543A1 - Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma. - Google Patents

Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Info

Publication number
ES2115543A1
ES2115543A1 ES09601755A ES9601755A ES2115543A1 ES 2115543 A1 ES2115543 A1 ES 2115543A1 ES 09601755 A ES09601755 A ES 09601755A ES 9601755 A ES9601755 A ES 9601755A ES 2115543 A1 ES2115543 A1 ES 2115543A1
Authority
ES
Spain
Prior art keywords
carbetocin
complexes
obtaining
pharmaceutically acceptable
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09601755A
Other languages
English (en)
Other versions
ES2115543B1 (es
Inventor
Rodriguez Fco Javier Clemente
Obiols Berta Ponsati
Duena Antonio Parente
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BCN Peptides SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Priority to ES9601755A priority Critical patent/ES2115543B1/es
Publication of ES2115543A1 publication Critical patent/ES2115543A1/es
Application granted granted Critical
Publication of ES2115543B1 publication Critical patent/ES2115543B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE CARBETOCINA Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES O COMPLEJOS DE LA MISMA. CONSISTE EN UN PROCEDIMIENTO SIMPLE DE SINTESIS EN FASE SOLIDA QUE CONSTA DE: 1) CONSTRUCCION DE LA ESTRUCTURA LINEAL CON LA INCORPORACION DEL ACIDO 4-CLOROBUTIRICO EN EL EXTREMO AMINO TERMINAL. 2) DESPROTECCION DEL GRUPO TIOL DE LA CISTEINA Y SIMULTANEA ROTURA DEL ENLACE PEPTIDO RESINA. 3) CICLACION INTRAMOLECULAR EN MEDIO BASICO POR ATAQUE NUCLEOFILO DEL GRUPO S- SOBRE EL GRUPO CL PARA FORMAR EL ENLACE TIOETER.
ES9601755A 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma. Expired - Fee Related ES2115543B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9601755A ES2115543B1 (es) 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9601755A ES2115543B1 (es) 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Publications (2)

Publication Number Publication Date
ES2115543A1 true ES2115543A1 (es) 1998-06-16
ES2115543B1 ES2115543B1 (es) 1999-02-16

Family

ID=8295767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9601755A Expired - Fee Related ES2115543B1 (es) 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Country Status (1)

Country Link
ES (1) ES2115543B1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103833831A (zh) * 2013-10-22 2014-06-04 海南双成药业股份有限公司 一种卡贝缩宫素的制备方法
CN112142825A (zh) * 2020-10-13 2020-12-29 山东辰龙药业有限公司 片段方式合成卡贝缩宫素的方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103467573B (zh) * 2013-09-02 2017-12-15 深圳翰宇药业股份有限公司 一种卡贝缩宫素的制备方法
CN103992390A (zh) * 2013-09-10 2014-08-20 杭州诺泰制药技术有限公司 一种合成卡贝缩宫素的方法
CN104592362A (zh) * 2015-01-05 2015-05-06 苏州天马医药集团天吉生物制药有限公司 卡贝缩宫素的合成工艺
CN112094324B (zh) * 2020-09-21 2022-05-03 宁波三生生物科技股份有限公司 一种卡贝缩宫素的合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS270051B1 (cs) * 1988-06-03 1990-06-13 Lebl Michal Analogy oxytocinu
WO1992018144A1 (en) * 1991-04-12 1992-10-29 Michal Lebl Substituted benzhydrylamines as handles for solid phase peptide synthesis
ES2055665A1 (es) * 1993-02-03 1994-08-16 Lipotec Sa Procedimiento para la obtencion de carbocalcitonina.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS270051B1 (cs) * 1988-06-03 1990-06-13 Lebl Michal Analogy oxytocinu
WO1992018144A1 (en) * 1991-04-12 1992-10-29 Michal Lebl Substituted benzhydrylamines as handles for solid phase peptide synthesis
ES2055665A1 (es) * 1993-02-03 1994-08-16 Lipotec Sa Procedimiento para la obtencion de carbocalcitonina.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS CA en STN, Chemical Abstracts, Columbus, Ohio, USA. Vol. 116, resumen n‘ 106809 & CS 270051 B1 (LEBL MICHAL) 27.02.91 * Resumen * *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103833831A (zh) * 2013-10-22 2014-06-04 海南双成药业股份有限公司 一种卡贝缩宫素的制备方法
CN112142825A (zh) * 2020-10-13 2020-12-29 山东辰龙药业有限公司 片段方式合成卡贝缩宫素的方法

Also Published As

Publication number Publication date
ES2115543B1 (es) 1999-02-16

Similar Documents

Publication Publication Date Title
AU668295B2 (en) N-acyl-N,N',N'-ethylenediaminetriacetic acid derivatives and process for preparing same
OA09323A (en) "Imadazo /4, 5-b/ quinolinyloxyalkanoic acid amides with enhanced water solubility".
DE69704433D1 (de) Herstellung von kohlenwasserstofflöslichen hydrocarbylaluminoxanen
LU91306I2 (fr) Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN)
IL130152A0 (en) Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclyamide compounds
AU2125300A (en) Cyclosporin derivatives and method for the production of said derivatives
ES2115543A1 (es) Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.
IE872983L (en) Peptides
PL347574A1 (en) N-arylsulfonyl amino acid omega amides
GB9914045D0 (en) Novel compounds
GR3018038T3 (en) Antitumor amino acid and peptide derivatives of 1,4-bis[ (aminoalkyl and hydroxyaminoalkyl)- amino]-5,8 dihydroxyanthraquinones.
IL153394A0 (en) Process for the preparation of 5-aminosalicyclic acid
DE69936527D1 (de) Verwendung von modifiziertem lysozyme c in der herstellung von pharmazeutika zur krankheitsbehandlung
CA2109433A1 (en) Substituted benzhydrylamines as handles for solid phase peptide synthesis
IL128566A0 (en) Process for preparing pharmacologically acceptable salt of N-1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid
HUT49846A (en) Process for producing n-(3',4'-dimethoxycinnamoyl)-anthranilic acid (tranilast)
IL125256A0 (en) N-(3,3-dimethylbutyl)-l-aspartyl-d-alpha- aminoalkanoic acid n-(s)-1- phenyl-1-alkanamide useful as a sweetening agent
WO2003014160A3 (en) Cd44 variants carrying heparan sulfate chains and uses thereof
HU9701064D0 (en) Process for producing n-(2-carboxy-5-chlor-phenyl) glycin
ZA991107B (en) Process for preparing 3-hydroxy-5-[(1,4,5,6-tetrahydro-5-hydroxy-2-pyrimidinyl)amino] benzoic acid.
WO1990000179A3 (fr) Nouvelles proteins, adn les codant et leur usage
AU4170099A (en) Haloethyl-2-[ (2,6-dichlorophenyl) amino] phenylacetoxyacetate derivatives and their use as an intermediate to synthesize aceclofenac
RU2000105081A (ru) Применение препарата "эсвицин" для лечения ревматоидного артрита
IL116262A0 (en) Processes for preparing ranitidine
AU571050B2 (en) N-substituted amino propane sulfonic acid derivatives

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980616

Kind code of ref document: A1

Effective date: 19980616

PC2A Transfer of patent

Owner name: BCN PEPTIDES, S.A.

Effective date: 20120905

FD2A Announcement of lapse in spain

Effective date: 20161125